Zobair Younossi, Jillian Kallman, John Kincaid – 26 February 2007 – Infection with HCV leads to an array of symptoms that compromise health‐related quality of life (HRQL). Chronic hepatitis C is treated primarily with pegylated interferon (peg‐IFN) and an inosine 5′ monophosphate dehydrogenase inhibitor, ribavirin (RBV), with the goal of achieving a sustained virologic response (SVR). SVR reduces the rate of hepatic fibrosis and other disease‐related complications and, in turn, increases HRQL.

Gerald Y.

Frank Dombrowski, Matthias Evert – 26 February 2007 – The microarchitecture of the liver is still not completely understood although various concepts of structural liver organization have been proposed. Among them, Rappaport's liver acinus stands out as one of the most accepted models. The correctness of this model, however, has also been doubted, and its applicability is hampered by the fact that the outlines of the liver acinus are disguised and nobody was ever able to give visual evidence by “unmasking” a simple liver acinus from the surrounding liver tissue.

Stephan Menne, Paul J. Cote, Scott D. Butler, Ilia A. Toshkov, John L. Gerin, Bud C. Tennant – 26 February 2007 – Resolution of hepatitis B virus (HBV) infection is characterized by coordinated humoral and cellular immune responses. Immunity is durable over decades, protecting the host from reinfection and potential activation of residual HBV. Woodchucks infected at birth with woodchuck hepatitis virus (WHV) cleared viremia and developed antibodies to surface antigen (anti‐WHs).

Nadeem Hussain, Jordan J. Feld, David E. Kleiner, Jay H. Hoofnagle, Reyes Garcia‐Eulate, Sushil Ahlawat, Deloris E. Koziel, Victoria Anderson, Dianne Hilligoss, Peter Choyke, John I. Gallin, T. Jake Liang, Harry L. Malech, Steven M. Holland, Theo Heller – 26 February 2007 – Chronic granulomatous disease (CGD) is a rare congenital disorder characterized by repeated bacterial and fungal infections. Aside from a high incidence of liver abscess, little is known about hepatic involvement in CGD. The aim of this study was to describe the spectrum of liver abnormalities seen in CGD.

Valerio De Stefano, Alessia Fiorini, Elena Rossi, Tommaso Za, Patrizia Chiusolo, Simona Sica, Giuseppe Leone – 26 February 2007

Mark D. Gorrell, Fiona J. Warner – 26 February 2007

Marlyn J. Mayo, Iorna Handem, Sandra Saldana, Heidi Jacobe, Yonas Getachew, A. John Rush – 26 February 2007 – Pruritus is frequently the most debilitating symptom of cholestatic liver diseases. Moreover, existing therapies are often ineffective. Recent small, retrospective case series reports suggest that serotonin reuptake inhibitors can improve pruritus. This study was undertaken to establish the dose of sertraline and to evaluate its efficacy for cholestatic pruritus.

Flavia Bortolotti, Maria Guido – 26 February 2007

26 February 2007